← All stories
Markets
What's Driving Oxford Cannabinoid Technologies As Clinical Evidence Replaces Sector Hype?
Highlights Oxford Cannabinoid Technologies is judged on trial milestones and development discipline rather than sector sentiment. The AIM All-Share outran London's larger benchmarks across the week just gone, easing the backdrop for junior…
Covered by 1 outlet
All coverage · 1 article